Year archive

IMUGENE LIMITED — 2013 filings

All 64 regulatory filings released by IMUGENE LIMITED (IMU) in 2013, sourced directly from the official regulator.

64 Filings

2013 Period

2013 filings (64)

Filing	Released	Lang
Initial Director's Interest Notice 2 pages 85.9KB Director's Dealing	2013-12-23	English
Becoming a substantial holder 2 pages 962.3KB Major Shareholding Notification	2013-12-23	English
Change of Director's Interest Notice 2 pages 142.5KB Director's Dealing	2013-12-23	English
Becoming a substantial holder 2 pages 96.9KB Major Shareholding Notification	2013-12-22	English
Becoming a substantial holder 2 pages 769.2KB Regulatory Filings	2013-12-22	English
Final Director's Interest Notice 2 pages 99.3KB Director's Dealing	2013-12-22	English
Change of Director's Interest Notice 2 pages 139.9KB Director's Dealing	2013-12-22	English
Becoming a substantial holder 2 pages 1.3MB Major Shareholding Notification	2013-12-22	English
Results of Meeting 1 page 137.0KB Declaration of Voting Results & Voting Rights Announcements	2013-12-19	English
Appendix 3B and Section 708A Notice 13 pages 439.1KB Capital/Financing Update	2013-12-19	English
Settlement of Biolife Science Qld Ltd Acquisition 1 M&A Activity	2013-12-19	English
Becoming a substantial holder 2 pages 108.1KB Major Shareholding Notification	2013-12-19	English
Imugene Secures Important Intellectual Property 1 p Regulatory Filings	2013-12-18	English
Investor Presentation 18 pages 6.6MB Investor Presentation	2013-12-09	English
Appendix 3B and Section 708A Notice 13 pages 433.1KB Share Issue/Capital Change	2013-12-08	English
AGM Presentation 15 pages 8.4MB AGM Information	2013-11-19	English
Results of Meeting 1 page 138.6KB Declaration of Voting Results & Voting Rights Announcements	2013-11-19	English
Notice of General Meeting/Proxy Form 57 pages 2.2MB Proxy Solicitation & Information Statement	2013-11-17	English
Appointment of Dr Axel Hoos as a Non-Executive Director 1 Board/Management Information	2013-11-05	English
Private Placement 1 page 112.3KB Capital/Financing Update	2013-11-03	English
Appendix 3B & Section 708A Notice 13 pages 434.4KB Capital/Financing Update	2013-10-30	English
Appendix 4C - quarterly 5 pages 161.7KB Interim / Quarterly Report	2013-10-23	English
Imugene to acquire Biolife Science Qld Limited 3 pages 653.7KB M&A Activity	2013-10-22	English
Presentation and Q&A - Acquisition of Biolife Science Qld 26 pages 4.0MB Investor Presentation	2013-10-22	English
Capital Raising Complete 1 page 89.2KB Capital/Financing Update	2013-10-22	English
Notice of Annual General Meeting/Proxy Form 27 pages 690.7KB AGM Information	2013-10-20	English
Trading Halt 2 pages 242.6KB Regulatory Filings	2013-10-20	English
Ceasing to be a substantial holder - JP 3 pages 29.0KB Major Shareholding Notification	2013-10-15	English
European patent for novel drug delivery technology 1 Regulatory Filings	2013-09-26	English
Annual Report to shareholders 80 pages 4.0MB Annual Report	2013-09-26	English
Updated Securities Trading Policy 6 pages 99.9KB Governance Information	2013-09-24	English
Becoming a substantial holder 2 pages 65.1KB Major Shareholding Notification	2013-09-19	English
Change in substantial holding from CGP 2 pages 80.6KB Regulatory Filings	2013-09-19	English
CGP: Shareholder Update 2 pages 262.7KB Regulatory Filings	2013-09-18	English
Imugene discontinues ibuprofen development 1 page 1 Regulatory Filings	2013-09-17	English
Appendix 3B and Section 708A Notice 13 pages 397.0KB Capital/Financing Update	2013-09-03	English
Preliminary Final Report 18 pages 519.1KB Annual Report	2013-08-28	English
Ceasing to be a substantial holder 2 pages 78.5KB Interim / Quarterly Report	2013-08-13	English
Vitamin D development program at commercialisation stage 2 pages 129.0KB Regulatory Filings	2013-08-07	English
Japanese patent for novel drug delivery technology 2 pages 145.2KB Regulatory Filings	2013-08-06	English
Appendix 3B - Release of shares from escrow 12 pages 303.1KB Capital/Financing Update	2013-07-31	English
Appendix 4C - quarterly 5 pages 160.3KB Interim / Quarterly Report	2013-07-28	English
Release of Shares from Escrow 1 page 74.9KB Share Issue/Capital Change	2013-07-10	English
Change of Director's Interest Notice 2 pages 143.0KB Director's Dealing	2013-06-06	English
Share Purchase Plan Results & $181K R&D Refund 1 pa Capital/Financing Update	2013-06-03	English
Appendix 3B - Share Purchase Plan 12 pages 298.4KB Capital/Financing Update	2013-06-03	English
Imugene progresses Vitamin D development program 2 pages 139.4KB Capital/Financing Update	2013-05-22	English
Research Report on Imugene Drug Delivery Technology 1 Regulatory Filings	2013-05-07	English
Shareholder Newsletter 4 pages 370.3KB Management Reports	2013-05-01	English
Investor Presentation 15 pages 2.2MB Investor Presentation	2013-04-30	English
Imugene granted Chinese patent 2 pages 128.0KB Regulatory Filings	2013-04-29	English
Share Purchase Plan - Cleansing Notice 1 page 106.2 Capital/Financing Update	2013-04-29	English
Share Purchase Plan 2 pages 109.0KB Capital/Financing Update	2013-04-29	English
Share Purchase Plan - Offer Document 21 pages 385.5KB Report Publication Announcement	2013-04-29	English
Appendix 4C - quarterly 5 pages 156.3KB Interim / Quarterly Report	2013-04-28	English
Imugene to be awarded Japanese patent 2 pages 157.4KB Regulatory Filings	2013-03-04	English
Half Yearly Report and Accounts 24 pages 1.4MB Interim / Quarterly Report	2013-02-27	English
Half Year Financial Results 2 pages 111.1KB Interim / Quarterly Report	2013-02-27	English
Appendix 3X - Initial Director's Interest Notice (NE) 2 pages 35.5KB Director's Dealing	2013-02-12	English
Appendix 3Z - Final Director's Interest Notice (FP) 2 pages 33.6KB Director's Dealing	2013-02-12	English
Appendix 3B & 708A Notice 11 pages 228.7KB Capital/Financing Update	2013-02-12	English
Imugene Announces Board and Management Changes 1 pa Board/Management Information	2013-02-10	English
Reply to Query - Appendix 4C 4 pages 196.7KB Regulatory Filings	2013-02-10	English
Appendix 4C - quarterly 5 pages 69.9KB Interim / Quarterly Report	2013-01-30	English

Filings by year

2026 53 filings
2025 103 filings
2024 70 filings
2023 105 filings
2022 122 filings
2021 150 filings
2020 90 filings
2019 69 filings
2018 66 filings
2017 58 filings
2016 52 filings
2015 60 filings
2014 57 filings
2013 64 filings
2012 41 filings
2011 13 filings
2010 20 filings
2009 17 filings
2008 34 filings
2007 35 filings
2006 29 filings
2005 31 filings
2004 50 filings
2003 40 filings
2002 12 filings